Cannabinol-C4 NEW
| Price | $1 | $1 | $1 |
| Package | 1kg | 10kg | 100kg |
| Min. Order: | 1kg |
| Supply Ability: | kg |
| Update Time: | 2024-03-27 |
Product Details
| Product Name: Cannabinol-C4 | CAS No.: 60007-99-0 |
| Min. Order: 1kg | Purity: 99%HPLC |
| Supply Ability: kg | Release date: 2024/03/27 |
It has been found that hemp CBD oil can be used in medicine, cosmetics, skin care products and health products. Medical grade cannabis CBD, with more than 99% content, is the jewel in the crown of cannabis. In recent years, low concentrations of CBD have appeared in health care products, food and skin care products. CBD has become the brightest "C position" among many cannabinoids with a broad market value. However, among these many cannabinoids, there are many players whose strength cannot be underestimated, which also means that there are many competitors waiting for the stage. Including Cannabigerol (CBG). CBDA (cannabidiolic acid) is a precursor to CBD (cannabidiol).
Company Profile Introduction
WFWMED Co., Ltd. was established in 2021, located in Xiamen Haicang Biomedical Industrial Park. The company focus on rare cannabinoids and their intermediates chemosynthesis .
# New drugs: DDS(Drug Delivery System)-CBD(Cannabinoids) drugs discovery and development
Other featured intermediates: CBD Intermediates/Peptide Intermediates/Nitroolefins Intermediates etc.
##R&D driven fine chemicals,Technical barriers & high-valued chemicals) supplier.
Our R&D Team: Over 35 Chemists, more than half of whom are doctors and masters in chemistry and pharmacy.
### Providing CMO and CDMO Service
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $7.00/1KG |
VIP2Y
|
Zhengzhou Anbu Chem Co.,Ltd
|
2023-11-23 | |
| $0.00/25μg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
| $0.00/1g |
VIP4Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2024-07-29 |
China- Since: 2021-04-15
- Address: 304, 3/F, Building B13, Biomedical Industrial Park, 2074 Wengjiao West Road, Haicang District, Xiame
INQUIRY